Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che-Leung Law

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|September 18, 2009
Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challengesChe-Leung Law, Iqbal S Grewal
Clinical Lymphoma & Myeloma|April 14, 2009
Novel antibody-based therapeutic agents targeting CD70: a potential approach for treating Waldenström's macroglobulinemiaChe-Leung Law, Julie A McEarchern, Iqbal S Grewal
Advances in Experimental Medicine and Biology|September 18, 2009
Targeting CD70 for human therapeutic useTamar E Boursalian, Julie A McEarchern, Che-Leung Law, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
The pharmacologic basis for antibody-auristatin conjugate activityStephen C Alley, Xinqun Zhang, Nicole M Okeley, et al.
Arthritis and Rheumatism|June 10, 2003
Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupusFrédéric Lajaunias, Akinori Ida, Shuichi Kikuchi, et al.
Oncogene|August 31, 2004
Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerJoseph Petroziello, Andrew Yamane, Lori Westendorf, et al.
Blood|October 3, 2007
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30Ezogelin Oflazoglu, Ivan J Stone, Kristine A Gordon, et al.
Molecular Cancer Therapeutics|March 26, 2017
Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody-Drug ConjugatesFu Li, Michelle Ulrich, Mechthild Jonas, et al.
Mabs|May 25, 2010
5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Martha Anderson, et al.
International Immunology|April 6, 2002
Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complexChe-Leung Law, Martha Hayden-Ledbetter, Sonya Buckwalter, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|September 18, 2009
Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challengesChe-Leung Law, Iqbal S Grewal
Clinical Lymphoma & Myeloma|April 14, 2009
Novel antibody-based therapeutic agents targeting CD70: a potential approach for treating Waldenström's macroglobulinemiaChe-Leung Law, Julie A McEarchern, Iqbal S Grewal
Advances in Experimental Medicine and Biology|September 18, 2009
Targeting CD70 for human therapeutic useTamar E Boursalian, Julie A McEarchern, Che-Leung Law, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
The pharmacologic basis for antibody-auristatin conjugate activityStephen C Alley, Xinqun Zhang, Nicole M Okeley, et al.
Arthritis and Rheumatism|June 10, 2003
Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupusFrédéric Lajaunias, Akinori Ida, Shuichi Kikuchi, et al.
Oncogene|August 31, 2004
Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerJoseph Petroziello, Andrew Yamane, Lori Westendorf, et al.
Blood|October 3, 2007
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30Ezogelin Oflazoglu, Ivan J Stone, Kristine A Gordon, et al.
Molecular Cancer Therapeutics|March 26, 2017
Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody-Drug ConjugatesFu Li, Michelle Ulrich, Mechthild Jonas, et al.
Mabs|May 25, 2010
5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Martha Anderson, et al.
International Immunology|April 6, 2002
Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complexChe-Leung Law, Martha Hayden-Ledbetter, Sonya Buckwalter, et al.
Pageof 3